Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Therapeutic Specialties
>
Urology
>
Aureon Labs
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3328396"]Looks like they just hired a new CFO - take notice of the bio (it was just edited to remove the part about how he "positioned his last company for acquisition.")</p><p><br /></p><p>Current bio:</p><p><br /></p><p>Mr. Van Nostrand joined Aureon Laboratories in January 2010. Prior to joining Aureon, he served as Executive Vice President and Chief Financial Officer at AGI Dermatics, Inc. Prior to his tenure at AGI Dermatics, Mr. Van Nostrand spent 21 years at OSI Pharmaceuticals, Inc., where he served as Senior Vice President, and Chief Compliance Officer, among other positions. Mr. Van Nostrand remains an active board member for Metabolix, Inc., Achillion Pharmaceuticals, Inc. and is affiliated with numerous organizations including the Association of Biofinance Officers, the New York Biotechnology Association, the Cold Spring Harbor DNA Learning Center Corporate Advisory Board and the Foundation Board of Farmingdale University. Mr. Van Nostrand is a certified public accountant and holds a B.S. in Accounting from Long Island University. He has also completed Advanced Management Studies at The Wharton School.</p><p><br /></p><p>Old bio:</p><p><br /></p><p>Mr. Van Nostrand brings to Aureon an extensive background in the financial and strategic management of healthcare companies. Most recently, he served as Executive Vice President and Chief Financial Officer at AGI Dermatics, Inc., <b>where he helped oversee the company's successful acquisition by a Fortune 500 cosmetics company.</b> Prior to his tenure at AGI Dermatics, Mr. Van Nostrand spent 21 years at OSI Pharmaceuticals, Inc., where he served as Senior Vice President, Chief Compliance Officer and Chief Financial Officer, among other positions. Mr. Van Nostrand remains an active board member for Metabolix, Inc., Achillion Pharmaceuticals, Inc. and is affiliated with numerous organizations including the Association of Biofinance Officers and the New York Biotechnology Association. Mr. Van Nostrand will assume responsibility for all financial aspects of the company's activities. </p><p><br /></p><p>I wonder why they revised that?[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3328396"]Looks like they just hired a new CFO - take notice of the bio (it was just edited to remove the part about how he "positioned his last company for acquisition.") Current bio: Mr. Van Nostrand joined Aureon Laboratories in January 2010. Prior to joining Aureon, he served as Executive Vice President and Chief Financial Officer at AGI Dermatics, Inc. Prior to his tenure at AGI Dermatics, Mr. Van Nostrand spent 21 years at OSI Pharmaceuticals, Inc., where he served as Senior Vice President, and Chief Compliance Officer, among other positions. Mr. Van Nostrand remains an active board member for Metabolix, Inc., Achillion Pharmaceuticals, Inc. and is affiliated with numerous organizations including the Association of Biofinance Officers, the New York Biotechnology Association, the Cold Spring Harbor DNA Learning Center Corporate Advisory Board and the Foundation Board of Farmingdale University. Mr. Van Nostrand is a certified public accountant and holds a B.S. in Accounting from Long Island University. He has also completed Advanced Management Studies at The Wharton School. Old bio: Mr. Van Nostrand brings to Aureon an extensive background in the financial and strategic management of healthcare companies. Most recently, he served as Executive Vice President and Chief Financial Officer at AGI Dermatics, Inc., [B]where he helped oversee the company's successful acquisition by a Fortune 500 cosmetics company.[/B] Prior to his tenure at AGI Dermatics, Mr. Van Nostrand spent 21 years at OSI Pharmaceuticals, Inc., where he served as Senior Vice President, Chief Compliance Officer and Chief Financial Officer, among other positions. Mr. Van Nostrand remains an active board member for Metabolix, Inc., Achillion Pharmaceuticals, Inc. and is affiliated with numerous organizations including the Association of Biofinance Officers and the New York Biotechnology Association. Mr. Van Nostrand will assume responsibility for all financial aspects of the company's activities. I wonder why they revised that?[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Therapeutic Specialties
>
Urology
>
Aureon Labs
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Therapeutic Specialties
>
Urology
>
Aureon Labs
>